Antioxidant Effects of CoQ10 in Transfusion-Dependent β-Thalassemia Major Patients: Implications for Ferroptosis-Related Pathways.

Elevated Fatty Acid Binding Protein 4 (FABP4) Associated With Liver Damage and Kidney Complications in Thalassemia Patients.

Patient-Reported Outcomes With Luspatercept Through 5 Years of Treatment in Patients With Non-Transfusion-Dependent β-Thalassemia Treated in the BEYOND Trial.

Genetics and Genomics in Sickle Cell Disease in Africa.

Curative Approach to the Treatment of Beta-Thalassemia and Sickle Cell Disease with Hematopoietic Stem Cell Transplantation.

Systematic Review of Non-Coding Genomic Variants in Globin and Non-Globin Clusters and Their Impact on Phenotypic Severity in Thalassemia and Sickle Cell Disease.

Endothelial dysfunction and cardiac damage indicators in patients with β-thalassemia major under iron-chelation therapy.

Comprehensive expression of long non-coding RNAs and association with iron and erythropoiesis regulatory proteins in transfusion-dependent β-thalassemia.

A Case Report of HLA 5/10 Cord Blood Cell Engraftment in a Patient with Severe β Thalassemia after Haplo-Cord Stem Cell Transplantation.

Alterations in Serum MAO Activity and Tau Levels in β-Thalassemia.

Adult survivors of sickle cell disease, transfusion-dependent beta-thalassaemia and childhood acute leukaemia in England: protocol for a mixed methods data linkage and health-related quality of life survey study.

Two Novel SUPT5H Variants Causing β-Thalassemia Trait Phenotypes.

A Retrospective Analysis of Blood Component Utilization and Transfusion-Related Factors in a Diverse Patient Population.

Clinical Applications of Ligand Traps Targeting Activin Type II Receptors.

Identification of RBM3 as a novel regulator of human fetal hemoglobin expression.

Carrier screening for multiple complex monogenic diseases using long-read sequencing: a population-based study of premarital couples in Shanghai.

Analysis of Hematological Parameters in Relation to Genotypes in 497 Patients with Hemoglobin H Disease.

CRISPR editing of HPFH3 genotype induces γ-globin expression and reverses sickle cell disease and β-thalassemia phenotypes.

Left ventricular strain and chamber dimensions in pediatric sickle cell disease: age-related reduction in myocardial deformation independent of hemolysis and hydroxyurea therapy.

Alterations in iron status predict cardiac response to blood transfusion in β-thalassemia major.

Effects of fluconazole and voriconazole on cyclosporine levels and toxicity in allogenic hematopoietic stem cell transplant recipients: A comprehensive analysis.

Family trios/quartets analysis based on the Newborn Genomic Atlas for Thalassemia project in Guangxi.

Liver Tissue Mapping in Transfusion-Dependent β-Thalassemia: Reproducibility and Clinical Insights from Multiparametric MRI.

Confounding Factors in the Diagnosis of Hereditary Spherocytosis and Gallstone Formation in Related Hemolytic Disorders From a Tertiary Care Center in North India.

Thalassemia and hypercoagulability.

Assessment of Adherence to Iron Chelation Therapy Among Thalassemia Patients in Palestine.

Epidemiology and economic burden of selected rare genetic diseases in Germany - a claims database study.

Metabolomic Investigation of Myelodysplastic Syndromes, Multiple Myeloma, and Homozygous β-Thalassemia.

The relation between sleep and pain sensitization in pediatric sickle cell disease.

Case Report: identification of a novel 9.159-kb deletion in a Chinese α-thalassemia family using single molecule real-time technology sequencing.

Predictive value of hepcidin and HIF1α protein levels for iron deposition in β-thalassemia.

Cellular and molecular targets in β-Thalassemia: advances in iron Regulation, Erythropoiesis, and Gene-Based therapies.

Genetic Analysis and Clinical Relevance of HBA1:c.305T > C (Leu > Pro): A Novel Variant Linked to α-Thalassemia.

Post-Load Plasma Glucose Increase (PG-gap) as a Risk Factor for Developing Dysglycemia in Patients with Transfusion-Dependent β-Thalassemia (β-TDT): Retrospective Analysis over 8 Years.

The cognitive profiles of people with β - Thalassemia across the life span: a systematic review.

Gene Therapies for Hemoglobinopathies: Efficacy, Cell Collection & Transfusion Support.

Genetic Analysis of a Patient with β-Thalassemia Major and Homozygous Hb Constant Spring in a Chinese Family.

Utility of long-read sequencing to delineate a rare large deletion of beta-globin gene which escaped Sanger sequencing at prenatal diagnosis in a family clustered with hereditary persistence of fetal hemoglobin.

Biopsy-proven Crescentic Glomerulonephritis Following Inhaled Methamphetamine Use: An Exceptional Case of Confirmed Drug-induced Glomerular Injury.

A Case Series on Beta Thalassemia Major With Secondary Diabetes Mellitus Due to Iron Overload and Other Complications.

A novel 17.9 kb deletion of the beta-globin gene causing beta-thalassemia trait in a Danish male.

Comprehensive regulation of γ-globin expression by epigenetic modifications and protein post-translational modifications.

Expression of Immune Checkpoints LAG-3, CTLA-4, TIM-3, and PD-1 in Beta-Thalassemia Patients Treated Using HbF Augmentation Therapy and Regular Transfusions.

Association of depression and hydroxyurea use with neuropathic pain in hemoglobinopathies.

Radiologic Evaluation of Paranasal Sinuses in Sickle Cell Anemia and Thalassemia: Case-Control Study.

Early thalassemia screening via hemoglobin β-subunit detection: a portable PDA-PoPD-MWCNT electrochemical immunosensor.

Histopathologic and Molecular Evidence of Splenic Infarction Associated with Sickle Cell Trait: An Instructive Case in Central America.

Clinical burden and healthcare resource utilization of patients with sickle cell disease and recurrent vaso-occlusive crises or transfusion-dependent beta-thalassemia in The Netherlands.

Coexistence of Hereditary Spherocytosis, Beta-Thalassemia Trait and Gilbert Syndrome in a Newborn: A Rare Genetic Profile.

Nonclinical evaluation of renizgamglogene autogedtemcel for SCD and TDT.

Effect of Therapy Reminder Application on Treatment Adherence in Adults with Beta-Thalassemia Major: A Randomized Clinical Trial.

From CBC to clarity: Interpretable detection of beta-thalassemia carriers in imbalanced datasets.

Genetic biomarkers and crucial cell subsets of iron metabolism in Beta-Thalassemia: insights from bioinformatics and experimental validation.

Beta Thalassemia Manifesting as a Leukemoid Reaction: A Rare Case Report.

The ENERGIZE trial: Is mitapivat ready to take center stage in NTDT management?

Challenges Associated with the Identification of Abnormal Hemoglobin Variants Utilizing the High-performance Liquid Chromatograph Technique: A Prospective Study in a Hospital Setting in Gujarat.

Nontrauma-Associated Cerebral Fat Embolism Syndrome in Sickle Cell-Related Hemoglobinopathies: A Case Series and Systematic Review.

Evaluation of hepatotoxicity due to conditioning regimens in beta thalassemia major and aplastic anemia patients undergoing bone marrow transplantation.

The disease burden of β-thalassaemia revisited.

Epigenetic mechanisms and next-gen editing platforms in hematology: From molecular basis to therapeutic frontiers.

Development of a low-cost and high-throughput LC-MS method for newborn screening of thalassemia and abnormal hemoglobin disorders.

Whole-Brain Analysis of Increased Brain Iron in Patients with β-Thalassemia.

Prevalence of the Main Human Genetic Variants Related to Resistance to Malaria in a Population of the Colombian Pacific Coast.

Exploring the role of consanguinity in thalassemia prevalence in Pakistan: an in-depth analysis of genetic and cultural factors affecting public health.

Magnitude of Beta-Hemoglobinopathies through Biomarkers among the Selected Tribes of Dharmapuri, Tamil Nadu: A Community-Based Cross-Sectional Study.

Pulmonary Hypertension Among Individuals Living With Hemoglobinopathies: A Systematic Review.

Colchicine induces developmental defects and renal toxicity in zebrafish by upregulating the oxidative stress.

Association of healthy eating behaviours and comorbidity on quality of life among adults with beta-thalassemia major: a moderation analysis.

Safety and Feasibility of Fertility Preservation and Fertility Outcomes in Patients with Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia Undergoing Gene Therapy.

Beyond the blood: A practical guide to thalassemia care in the emergency department.

Impact of lifetime anaemia and iron control on outcomes in β-thalassaemia: Data from the longitudinal de-LIGHT study.

A case of erosive oral lichen planus in a child affected by β-Thalassemia after 5 years from bone marrow transplantation.

Psychosocial Problems in the Siblings of Multitransfused Thalassemia Patients.

Characterisation of β-thalassemia mutations in a tertiary care referral hospital in southern India- A descriptive study.

Single-cell RNA sequencing uncovers abnormal Sertoli-cell elevation and testicular niche impairment in the transfemales's testis.

Disrupting ZBTB7A or BCL11A binding sites reactivates fetal hemoglobin in erythroblasts from healthy and β0-thalassemia/HbE individuals.

Unveiling Rare Hemoglobinopathies: Hematologic Characterization of Double Heterozygous Hb D and Hb E With Beta-Thalassemia-A Case Report.

CRISPR-based therapeutic genome editing for inherited blood disorders.

Co-Induction of ULK-1 and AHSP mRNAs in Erythroid Precursor Cells Isolated From a Sirolimus-Treated β-Thalassemia Patient: A Case Report Study.

Outcomes of Unrelated Donor Stem Cell Transplantation with Partial T Cell Depletion for Pediatric Patients with Hemoglobinopathies.

Current Landscape of Hepcidin Therapeutics.

Sickle Cell Hepatopathy With Acute Hepatic Sequestration and Extreme Hyperbilirubinemia.

Orphan Nuclear Receptors TR2 and TR4 in Erythropoiesis: From Mechanisms to Therapies.

Ischemic Stroke as the Initial Presentation of Sickle Beta Thalassemia in an Adolescent: A Case Report.

Thalassemia in Sub-Saharan Africa: epidemiology, diagnosis, and management - a narrative review.

To pursue gene therapy or not? Is it feasible after graft failure in allogeneic hematopoietic cell transplant recipients.

Plasma Zinc and Magnesium Levels in Sickle Cell Disease Patients in Latakia, Syria.

The phenotypes of sickle cell disease: strategies to aid the identification of undiagnosed patients in the Italian landscape.

Potential applications of components of aged garlic extract in mitigating pro-inflammatory gene expression linked to human diseases (Review).

[Delayed physical growth and related factors in pediatric patients with transfusion-dependent thalassemia].

Spectrum of Ophthalmic Manifestations in Patients With Transfusion-Dependent Thalassemia.

Novel, potent, and orally bioavailable LSD1 inhibitors induce fetal hemoglobin synthesis in a sickle cell disease mouse model.

FACTORS AFFECTING HEALTH RELATED QUALITY OF LIFE IN ADULT PATIENTS WITH BETA-THALASSEMIA MAJOR.

Therapeutic promise of CRISPR-Cas9 gene editing in sickle cell disease and β-thalassemia: A current review.

A comprehensive case study of deep learning on the detection of alpha thalassemia and beta thalassemia using public and private datasets.

Health-related quality of life and economic impacts in adults with transfusion-dependent β-thalassemia: findings from a prospective longitudinal real-world study.

Evaluated NSUN3 in reticulocytes from HbH-CS disease that reflects cellular stress in erythroblasts.

Outcome of Haematopoietic Stem Cell Transplant in Beta-Thalassaemia Major: Single Centre Experience from a Low- and Middle-Income Country.

Genetic landscape and hematological profiling of thalassemia in patients from the Malwa region, Central India.

A rare -α27.6 deletion compounded with the hemoglobin constant spring mutation identified in a Chinese couple.

Rickettsia Felis Case Cluster in a Military Family.

Application value of long-read sequencing in full characterization of thalassemia-associated structural variations: identifying a novel large segmental duplication and literature review.

Clinical Outcomes Among Patients With Sickle Cell Disease and Transfusion-Dependent Beta-Thalassemia Treated With Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Literature Review.

Biosensing of single-nucleotide polymorphism: Technological advances and their transformative applications on health.

Unusual Causes of β Thalassemia Trait: Discovery of another Three Novel SUPT5H Variants.

A challenging convergence of conditions in a patient with thalassemia major presenting with thymoma and lymphangioleiomyomatosis: a case report.

Kawasaki-like illness following COVID-19 infection in a minor β-thalassemic girl.

Prevalence and Detection of Novel Thalassemia Variant hemoglobin J in Extensive Tharu Population.

Characterization Of Beta Thalassaemia Mutations In Patients Having Borderline Haemoglobin A2 Levels.

Creating New Cis-Regulatory Elements of HBD to Reactivate Delta-Globin.

Comparative analysis of mortality patterns and treatment strategies in thalassaemia and sickle cell disease patients: A 12-year study.

Experiences of family caregivers of children living with thalassaemia-major in Karachi: a phenomenological study.

Novel AK-1 gene variants combined with thalassemia causing rare hereditary non-spherocytic hemolytic anemia in a Chinese family.

Rapid detection of genetic modifiers of β-thalassemia based on MALDI-TOF MS.

Experiences of traumatized mothers caring for their thalassemia children after the earthquakes in Turkey and their expectations from nurses: a qualitative study.

Two Nonmyeloablative HLA-Matched Related Donor Allogeneic Hematopoietic Cell Transplantation Regimens in Patients with Severe Sickle Cell Disease.

Exploratory Review and In Silico Insights into circRNA and RNA-Binding Protein Roles in γ-Globin to β-Globin Switching.

Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trial.

Successful Second Hematopoietic Stem Cell Transplantation Using Total Body Irradiation-Based Conditioning for Children With Transfusion-Dependent Beta-Thalassemia.

Male reproductive phenotype alterations in heterozygous β-globin gene knockout thalassemia (BKO) mice as a model for β-thalassemia patients.

Evaluation of β-thalassemias in the premarital hemoglobinopathy screening program: A retrospective study.

Automated Quantitative Assessment of Retinal Vascular Tortuosity in Patients with Sickle Cell Disease.

Navigating Hope and Complexity: Turkish Parents’ Experiences with Savior Siblings.

Dual α-globin-truncated erythropoietin receptor knockin restores hemoglobin production in α-thalassemia-derived erythroid cells.

Association of Serum Ferritin With Growth and Endocrine Function in Thalassemia Major Children in North India: An Observational Study.

First clinical and pedigree study of rare HBB: c.316-90 A > G variant in β-globin gene in Chinese population using third-generation sequencing.

Bone and Joint Involvement in Beta Thalassemic Patients: A Cross-sectional Study.

[Clinical characteristics of cytokine release syndrome after haploidentical hematopoietic stem cell transplantation for thalassemia major].

Early Engraftment and Immune Kinetics Following Allogeneic Transplant Using a Novel Reduced-Toxicity Transplant Strategy in Children/Adolescents with High-Risk Transfusion-Dependent Thalassemia: Early Results of the ThalFAbS Trial.

Mutations in AMBRA1 aggravate β-thalassemia by impairing autophagy-mediated clearance of free α-globin.

Standardization of hemoglobin A2 and hemoglobin F: Achievements and perspectives.

Convolutional neural networks for automatic MR classification of myocardial iron overload in thalassemia major patients.

Burden of illness of non-hematopoietic stem cell transplant-related hepatic sinusoidal obstruction syndrome: A systematic review.

Therapeutic potential of synthetic and natural iron chelators against ferroptosis.

Exploring Novel Strategies to Alleviate Symptoms of β-Globinopathies: Examining the Potential Role of Embryonic ε-globin Induction.

The Validation of Whole β-Globin Gene Sequencing for Detecting β-Thalassemia Mutations Found in Thailand Using Next-Generation Sequencing (NGS).

Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial.

Association of age to nutritional status and muscle mass in children with transfusion-dependent β-thalassemia: a cross-sectional study.

Whole Blood Transcriptome Analysis in Congenital Anemia Patients.

Genetic Polymorphisms Associated with Fetal Hemoglobin (HbF) Levels and F-Cell Numbers: A Systematic Review of Genome-Wide Association Studies.

Memantine treatment in sickle cell disease: A 1-year study of its effects on cognitive functions and neural processing.

Existing Tubular Injury in β-Thalassemia Major Patients Receiving Iron Chelating Agents with Normal Creatinine Level in East Java, Indonesia.

Clinical Burden and Healthcare Resource Utilization Associated With Managing Transfusion-dependent β-Thalassemia in England.

Health-related quality of life and associated factors among children with Transfusion-dependent β-thalassaemia: a cross-sectional study in Guangxi Province.

Health-Related Quality of Life of Adolescents With Non-transfusion-Dependent Thalassemia in Basrah, Iraq.

Gene Therapy: A Revolutionary Step in Treating Thalassemia.

Impact of Empagliflozin on the Outcomes of β-Thalassemia Major in Patients With Type 2 Diabetes Mellitus: The THALEMPA Observational Study.

Differential gut microbiota composition in β-Thalassemia patients and its correlation with iron overload.

Characterization of a novel 8.2 kb deletion causing beta-thalassemia.

Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in hematological diseases.

Relationship between hemoglobinopathies and male infertility: a scoping review.

Case report: A rare heterozygous Hb CS with heterozygous HbE in a family with thalassemia in China.

Trans-acting genetic modifiers of clinical severity in heterozygous β-Thalassemia trait.

Systematic literature review of the indirect costs and humanistic burden of β-thalassemia.

Rhabdomyolysis in a Case of Mild Coronavirus Disease 2019 and β-Thalassemia Minor.

In vivo silencing of intestinal DMT1 mitigates iron loading in β-thalassemia intermedia (Hbbth3/+) mice.

ATG-Thymoglobulin Versus ATG-Fresenius for Conditioning in Thalassemia Patients Who Underwent Allogenic Stem Cell Transplantation from Matched-Sibling Donor: A Tertiary Cancer Care Center Short-Term Experience.

Acute Pancreatitis in Individuals with Sickle Cell Disease: A Systematic Review.

Regulatory Assessment of Casgevy for the Treatment of Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-Occlusive Crises.

Causes of Death and Mortality Trends in Individuals with Thalassemia in the United States, 1999-2020.

Assessing NESTROFT as a preliminary screening tool for thalassemia in the Malayali tribes of Dharmapuri district, Tamil Nadu, India.

Assessing Psychological Disorders in Turkish Adolescents with Transfusion-Dependent Thalassemia.

A comprehensive review on the current status of CRISPR based clinical trials for rare diseases.

Manuka combinations with nigella sativa and hydroxyurea in treating iron overload of pediatric β-thalassemia major, randomized clinical trial.

Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient.

Ovarian Tissue Cryopreservation for Fertility Preservation in Patients with Hemoglobin Disorders: A Comprehensive Review.

Appropriateness of the EQ-5D-5L in capturing health-related quality of life in individuals with transfusion-dependent β-thalassemia: a mixed methods study.

Health-related Quality of Life of Omani Adult Patients with β-Thalassemia Major at Sultan Qaboos University Hospital.

International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges faced.

Optimizing the management of inherited blood disorders in a changing market: Findings from the AMCP Market Insights Program.

Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot study.

Prevalence of HIV, hepatitis B and hepatitis C infections among patients with thalassemia attending a tertiary care (rural) hospital.

[Overview of new approaches to β-thalassemia treatment].

Therapeutic Nonsense Suppression Modalities: From Small Molecules to Nucleic Acid-Based Approaches.

A New Formula Based on Simple Blood Indices to Differentiate Beta Thalassemia Trait from Iron Deficiency Anemia.

Exploring the perceptions and experiences of female's with ß-thalassemia major in a Tertiary Care Private Hospital in Pakistan.

Murine models of erythroid 5ALA synthesis disorders and their conditional synthetic lethal dependency on pyridoxine.

Systematic review and evidence gap assessment of the clinical, quality of life, and economic burden of alpha-thalassemia.

How Age, Sex and Transfusion Affects the Incidence of Endocrine and Bone Density Disorders in Major Thalassemic Patients.

Therapeutic Relevance of Inducing Autophagy in β-Thalassemia.

A moonlighting job for α-globin in blood vessels.

Comparison of Yearly Cost Related to Complications Between Deferasirox and Deferiprone Monotherapy in Thalassemia.

Liver disease in patients with transfusion-dependent β-thalassemia: The emerging role of metabolism dysfunction-associated steatotic liver disease.

Iron burden and endocrine complications in transfusion-dependent thalassemia patients In Sarawak, Malaysia: a retrospective study.

Application of short tandem repeats (STRs) in the preimplantation genetic diagnosis (PGD) of α-thalassemia.

Dual α-globin and truncated EPO receptor knockin restores hemoglobin production in α-thalassemia-derived red blood cells.

Nutritional and Body Composition Changes in Paediatric β-Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Retrospective Study Using Bioelectrical Impedance Analysis.

Pulmonary Hypertension in Sickle Cell Disease: Novel Findings of Gene Polymorphisms Related to Pathophysiology.

Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications.

Screening for thalassemia carriers among the Han population of childbearing age in Southwestern of China.

Detection of CRISPR/Cas9-Mediated Fetal Hemoglobin Reactivation in Erythroblasts Derived from Cord Blood-Hematopoietic Stem Cells.

Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in β-thalassemic mice.

Good engraftment after reduced intensity targeted busulfan-based conditioning and matched related donor hematopoietic cell transplantation in hemoglobinopathies.

Survival and causes of death in patients with alpha and beta-thalassemia in Northern Thailand.

Proportion of Hypogonadism in Transfusion-Dependent Thalassemia Patients and Its Contributing Factors.

Prevalence of common autosomal recessive mutation carriers in women in the Southern Vietnam following the application of expanded carrier screening.

Health-Related Quality-of-Life Impacts Associated with Transfusion-Dependent β-Thalassemia in the USA and UK: A Qualitative Assessment.

Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with β-thalassemia.

Outcomes of Haematopoietic Stem Cell Transplantation in Beta Thalassemia Major with Fully Matched Parents as Donor.

Compound heterozygosity for Southeast Asian hereditary persistence of fetal hemoglobin and β0-thalassemia results in thalassemia intermedia: Pedigree analysis and genetic research in a family from South China. A case report.